Innovative Diagnostic Technology NOWDx specializes in rapid, accurate immunological assays with patented a one-step testing approach, providing fast results for over-the-counter and point-of-care markets. This technological edge offers opportunities to expand into various healthcare and retail distribution channels seeking reliable onsite diagnostics.

Growing Product Portfolio With recently launched tests like the First To Know Syphilis Test and ongoing development of COVID-19 diagnostics, NOWDx demonstrates a pipeline of innovative, high-demand health tests. Partnering with labs and healthcare providers can support deployment across clinics, hospitals, and at-home testing markets.

Strategic Collaborations Recent partnerships with LabCorp and participation in major healthcare events position NOWDx as a trusted collaborator. There are opportunities to expand relations with healthcare distributors and major health systems to accelerate market penetration and sales growth.

Funding and Growth Potential Recent Series B funding of $22.5 million underpins the company's expansion plans and product development. Engaging with investors and leveraging these funds could help scale manufacturing capabilities and expand geographically, opening new sales avenues.

Market Expansion Readiness Operating in a growing global market for accessible, in-home testing aligned with increasing demand for rapid diagnostics, NOWDx’s focus on innovative OTC and POC tests creates significant opportunities for strategic distribution in both healthcare settings and retail environments.